Axikin Pharmaceuticals' Series C Round

Axikin Pharmaceuticals raised a round of funding on March 27, 2014. Investors include Sanderling Ventures.

Axikin Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutics for respiratory disorders including allergic rhinitis, ashtam and COPD. The Axikin discovery biology an…

Articles about Axikin Pharmaceuticals' Series C Round: